Luke Corning's most recent trade in Poseida Therapeutics Inc was a trade of 58,950 Common Stock done . Disclosure was reported to the exchange on Jan. 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Poseida Therapeutics Inc | Luke Corning | Director | 08 Jan 2025 | 58,950 | 0 | - | - | Common Stock | ||
| Poseida Therapeutics Inc | Luke Corning | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 08 Jan 2025 | 45,833 | 0 | - | - | Stock Option (Right to Buy) | |
| Poseida Therapeutics Inc | Luke Corning | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 08 Jan 2025 | 28,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Poseida Therapeutics Inc | Luke Corning | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 08 Jan 2025 | 27,350 | 0 | - | - | Stock Option (Right to Buy) | |
| Poseida Therapeutics Inc | Luke Corning | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 08 Jan 2025 | 27,350 | 0 | - | - | Stock Option (Right to Buy) | |
| Poseida Therapeutics Inc | Luke Corning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 27,350 | 27,350 | - | - | Stock Option (Right to buy) | |
| Poseida Therapeutics Inc | Luke Corning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 19,650 | 58,950 | - | 0 | Common Stock | |
| Poseida Therapeutics Inc | Luke Corning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 27,350 | 27,350 | - | - | Stock Option (Right to buy) | |
| Poseida Therapeutics Inc | Luke Corning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 19,650 | 39,300 | - | 0 | Common Stock | |
| Poseida Therapeutics Inc | Luke Corning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 28,500 | 28,500 | - | - | Stock Option (Right to Buy) | |
| Poseida Therapeutics Inc | Luke Corning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 19,650 | 19,650 | - | 0 | Common Stock | |
| Poseida Therapeutics Inc | Luke Corning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 45,833 | 45,833 | - | - | Stock Option (Right to Buy) |